---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-299375"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:55:59.024446+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amylyx CMO Patrick Yeramian moves to part-time, salary reduced to $214K; successor search ongoing

## Summary
- CMO Patrick Yeramian's working hours reduced to 20 per week as of Dec 1, 2022.
- Base salary adjusted to $214,000 annually from prior rate (not disclosed).
- Company expects Yeramian to transition into retirement; no definitive date set.
- Full-time successor search initiated as part of management succession process.
- Yeramian's reduced schedule not the result of any disagreement with the company.

## SEC filing metadata
- accession: 0001193125-22-299375
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312522299375/0001193125-22-299375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312522299375/d356648d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-299375
- JSON: https://secwatch.observer/filing/0001193125-22-299375.json
- Plain text: https://secwatch.observer/filing/0001193125-22-299375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.